Our previous study in a large DLBCL cohort revealed that SOX9 was highly expressed in BCL2‐overexpressing DLBCL subsets, providing evidence that BCL2 may modulate SOX9 expression. The gene discussed is SOX9; the disease is diffuse large B-cell lymphoma.